HepQuant’s unique technology provides accurate, safe, and cost-effective liver function testing to enable chronic liver disease research and drug development.
HepQuant is an early-stage medical diagnostics company with unique, patented and patent-pending noninvasive liver tests: HepQuant-SHUNT, -FLOW, and -STAT. Revenue is based on contracts for test performance and lab analysis. In Phase 1 of our business plan, we will focus on expanding accounts with pharma partners and liver research centers. In Phase 2, we will directly market tests to care providers, insurers, and third-party payors.